ProCE Banner Activity

COAST: Comparison of Baseline Characteristics and Ixekizumab Response Through Week 52 by Sex Among Patients With Axial Spondyloarthritis

Slideset Download
Conference Coverage
Although disease activity improved with ixekizumab treatment regardless of sex, time to improvement and peak response was longer for females vs males.

Released: July 26, 2021

Expiration: July 25, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Janssen administered by Scientific Affairs